Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

Bibliographic Details
Main Author:	Udo Bonnet
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Psychiatry
Subjects:	antidepressants SNRI SSRI COVID-19 adverse effects panic attacks
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1095244/full

Similar Items

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01)

Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants
by: Luis M. Garcia-Marin, et al.
Published: (2023-11-01)

Access to a tailored mobile application enhances medication adherence among young users of antidepressants
by: Rønnaug Eline Larsen, et al.
Published: (2024-04-01)

Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
by: Milica M. Borovcanin, et al.
Published: (2022-10-01)

Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
by: Amke Müller, et al.
Published: (2023-10-01)

The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
by: Dena Firouzabadi, et al.
Published: (2022-11-01)

Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings
by: Daphne E. Boucherie, et al.
Published: (2023-01-01)

A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
by: Saeed Pournaghash tehrani, et al.
Published: (2018-03-01)

Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
by: S. Sneep, et al.
Published: (2022-06-01)

Sertraline and Alprazolam in the Treatment of Panic Disorder
by: Saida Fišeković, et al.
Published: (2005-05-01)

Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis
by: Ramin Abdi Dezfouli, et al.
Published: (2024-01-01)

Selective serotonin reuptake inhibitors related bleeding risk: case report and review of literature
by: Andrea Boccatonda, et al.
Published: (2023-08-01)

Antidepressant drug treatment protecting from COVID-19: one more piece in the repurposing puzzle
by: Julia C. Stingl
Published: (2022-01-01)

Post-Selective Serotonin Reuptake Inhibitor Sexual Dysfunctions (PSSD): Clinical Experience with a Multimodal Approach
by: Yacov Reisman, et al.
Published: (2022-08-01)

Pharmacological-assisted Psychotherapy for Post Traumatic Stress Disorder: a systematic review and meta-analysis
by: Mathew D. Hoskins, et al.
Published: (2021-01-01)

Development of a multivariate prediction model for antidepressant resistant depression using reward-related predictors
by: Xiao Liu, et al.
Published: (2024-03-01)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
by: Stefania Chiappini, et al.
Published: (2022-05-01)

Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy
by: Keisuke Mori, et al.
Published: (2024-03-01)

ROLE OF SEROTONIN IN FISH REPRODUCTION
by: Parvathy ePrasad, et al.
Published: (2015-06-01)

Molecular Bases of Serotonin Reuptake Inhibitor Antidepressant-Attributed Effects in COVID-19: A New Insight on the Role of Bradykinins
by: Ahmed S. Gouda, et al.
Published: (2022-09-01)

The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024-02-01)

A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease
by: Jinli Zhang, et al.
Published: (2023-05-01)

Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases
by: Udo Bonnet, et al.
Published: (2024-02-01)

Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study
by: Allison L. Moreau, et al.
Published: (2023-04-01)

Investigating the relationship between quality of life and personality dimensions in serotonin reuptake inhibitors antidepressant drugs users
by: fatemeh shahcheraghi, et al.
Published: (2019-12-01)

The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features
by: Chia‐Chien Liu, et al.
Published: (2024-03-01)

Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
by: Kevin P. Kennedy
Published: (2022-10-01)

TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli
by: Jin Ou, et al.
Published: (2022-12-01)

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history
by: D. S. Danilov
Published: (2018-12-01)

Antidepressant drug prescription and incidence of COVID-19 in mental health outpatients: a retrospective cohort study
by: Oleg O. Glebov, et al.
Published: (2023-06-01)

TED—Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode—Preliminary Report
by: Marcin Siwek, et al.
Published: (2023-01-01)

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
by: Hugo R. Arias, et al.
Published: (2021-04-01)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
by: Najmeh Shahini, et al.
Published: (2021-07-01)

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
by: Yu. V. Solomatin, et al.
Published: (2016-12-01)

Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history
by: D. S. Danilov
Published: (2015-03-01)

Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder
by: Buket Belkız Güngör, et al.
Published: (2019-10-01)

The risk of an acute attack of angle-closure glaucoma during the treatment with modern antidepressant drugs
by: T. V. Romanova, et al.
Published: (2018-02-01)

A rare case with suicide due to akathisia after use of single dose venlafaxine
by: Nermin Gündüz, et al.
Published: (2018-06-01)

Exploring the effects of depression and treatment of depression in reinforcement learning
by: Pedro eCastro-Rodrigues, et al.
Published: (2013-10-01)

Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
by: Nastaran Eizadi-Mood, et al.
Published: (2022-12-01)